Abstract:Objective:To observe the effects of transurethral split of the prostate (TUSP) on the urodynamics, the sexual function and the quality of life of benign prostatic hyperplasia.Methods:Eighty patients with benign prostatic hyperplasia admitted to the Deqing People′s Hospital of Zhejiang Province from January 2017 to June 2019 were enrolled into the research objects prospectively. According to the random digits table method, they were divided into group A and group B, with 40 cases in each group. The group A was treated with TUSP, while the group B was treated with bipolar transurethral plasma kinetic prostatectomy (TUPKP). The operation time, intraoperative blood loss, bladder irrigation time, urinary catheter indwelling time, hospitalization time of the two groups were compared and surgical effects were evaluated. The changes of hemoglobin (Hb), serum sodium (Na), post-void residual volume (PVR), maximum urinary flow rate (Q max), international prostate symptom score (IPSS) and international index of erectile function score (IIEF-5), the quality of life index (QOL) of 2 groups before and after the operation were measured. Surgical complications were recorded. Results:The operation time, bladder irrigation time, urinary catheter indwelling time and hospital stay in group A were all shorter than that in group B: (15.63 ± 4.17) min vs. (58.79 ± 10.45) min, (6.26 ± 1.17) h vs. (45.51 ± 10.03) h, (3.07 ± 0.68) d vs. (5.67 ± 1.51) d, (3.63 ± 0.43) d vs. (6.08 ± 1.72) d, (18.32 ± 2.79) ml vs. (65.26 ± 20.64) ml, and there were statistical differences ( P<0.05); there were no statistical difference between 2 groups in surgical curative effect grade and Na 1 d after operation ( P>0.05); 1 day after operation, Hb in group A was higher than that in group B: (115.63 ± 9.78) g/L vs. (109.65 ± 8.36) g/L, and there was statistical difference ( P<0.05); PVR, Q max, IPSS, IIEF-5 and QOL 3 and 6 months after surgery were improved in 2 groups ( P<0.05), but the difference between 2 groups was not statistically significant ( P>0.05); the total complication rate in group A was lower than that in group B: 10.00% (4/40) vs. 27.50% (11/40), and there was statistical difference ( P<0.05). Conclusions:TUSP and TUPKP are equally effective in the treatment of benign prostatic hyperplasia, both of which can improve the symptoms of prostatic hyperplasia, improve the quality of life and improve sexual function. But TUSP has less intraoperative bleeding, shorter operation time, faster postoperative recovery, fewer complications, and higher safety.

Clinical application of a new spiral thermo-expandable prostatic stent

[Spiral thermo-expandable prostatic stent implantation for benign prostatic hyperplasia: Clinical analysis of 26 cases].

The value of transurethral cylindrical dilatation of the prostate in the treatment of patients with benign prostatic hyperplasia

A comparative study of two means of simultaneous treatment for benign prostate hyperplasia and bladder stone

Treating bladder-outflow obstruction with thermo-expandable prostate metal stents

Prostatic stents: a narrative review of current evidence

A Novel Thermo-Expandable Ureteral Metal Stent for the Minimally Invasive Management of Ureteral Strictures

Early Experience With a Thermo-Expandable Stent (Memokath) for the Management of Recurrent Urethral Stricture

The Metallic Stent Therapy for Senile Patients with Benign Prostatic Hyperplasia

A Retrievable Polymer Urethral Stent for Treatment of Urethral Strictures

Thermo-expandable intraprostatic nitinol stents in the treatment of bladder outlet obstruction: a consecutive case series

Long-term Effect of Finasteride on High-Risk Patients with Benign Prostatic Hyperplasia after Implantation of Thermo-Expandable Spiral Prostatic Stent

Memokath Stent Failure in Recurrent Bulbar Urethral Strictures: Results From an Investigative Pilot Stage 2A Study

[Efficacy and Safety of Digestive Tract Stent Placement under Direct Visual Endoscopy Without X-ray Monitoring in Treatment of Digestive Tract Stricture].

Efficacy and Safety of Transurethral Columnar Balloon Dilation of the Prostate for the Treatment of Benign Prostatic Hyperplasia: A Multicenter Trial

Safety and efficacy of thermo-expandable metallic stent in ureteral stricture following gynecological malignancy surgery and radiotherapy: a single center experience with 33 cases

Recent Advancements in Prostate Catheters and Stents for Management of Benign Prostatic Hyperplasia

New developments in the use of prostatic stents

Photoselective potassium-titanyl-phosphate laser vaporization prostatectomy for the treatment of high-risk patients with benign prostatic hyperplasia

Efficacy Evaluation of Stentless Minimally Invasive Percutaneous Nephrolithotomy

Short-term Clinical Evaluation of Photoselective Vaporization of the Prostate for the Patients with Benign Hyperplasia of Prostate in Anti-Coagulanting Status